Frentizole is primarily used in medical research and therapeutic applications due to its immunomodulatory properties. It has been studied for its potential to treat autoimmune diseases by modulating the immune system's response, thereby reducing inflammation and tissue damage. Additionally, Frentizole has shown promise in the treatment of viral infections, particularly in inhibiting the replication of certain viruses. Its application in experimental models has provided insights into its mechanism of action, which involves the suppression of immune cell activity. This makes it a candidate for further development in therapies targeting conditions where immune system regulation is critical.